BRIEF published on 09/29/2025 at 10:39, 7 months 13 days ago Genmab to Acquire Merus for USD 8 Billion Acquisition Investment Oncology Genmab Merus
PRESS RELEASE published on 09/29/2025 at 10:34, 7 months 13 days ago Genmab to Acquire HBM Portfolio Company Merus for USD 8 billion in Cash Genmab to acquire HBM portfolio company Merus for USD 8 billion in cash. Merus is known for its innovative oncology therapies. The transaction with Genmab represents a 41% premium on the closing price Acquisition Oncology HBM Healthcare Genmab Merus
BRIEF published on 09/16/2025 at 17:52, 7 months 25 days ago HBM Healthcare Investments AG Reports Modest Growth in September 2025 Financial Results Net Asset Value Investment Performance Share Price HBM Healthcare
BRIEF published on 09/16/2025 at 17:52, 7 months 25 days ago HBM Healthcare Investments AG annonce une croissance modeste en septembre 2025 Résultats Financiers Cours De L'action Performance Des Investissements HBM Santé Valeur Nette D'inventaire
PRESS RELEASE published on 09/16/2025 at 17:47, 7 months 25 days ago Key Figures 15.09.2025 HBM Healthcare Investments AG reports key figures for 15.09.2025 in CHF. NAV at 245.43, Share Price at 178.00, and Total Net Assets at 1,641 million. Performance percentages shown Performance HBM Healthcare Investments AG Key Figures CHF 15.09.2025
BRIEF published on 09/10/2025 at 08:40, 8 months 2 days ago Swixx BioPharma and Lundbeck Forge Multi-Regional CNS Partnership Emerging Markets Swixx BioPharma Healthcare Investments Lundbeck CNS Partnership
BRIEF published on 09/10/2025 at 08:40, 8 months 2 days ago Swixx BioPharma et Lundbeck forment un partenariat multirégional pour le SNC Marchés Émergents Swixx BioPharma Investissements Dans Les Soins De Santé Lundbeck Partenariat CNS
PRESS RELEASE published on 09/10/2025 at 08:35, 8 months 2 days ago HBM Portfolio Company Swixx BioPharma and Lundbeck Sign Multi-Regional CNS Partnership HBM Healthcare Investments announces partnership between Swixx BioPharma, Lundbeck for CNS therapies in South-East Europe, Turkey and Latin America Partnership HBM Healthcare Investments CNS Therapies Swixx BioPharma Lundbeck
BRIEF published on 09/01/2025 at 17:52, 8 months 10 days ago HBM Healthcare Investments AG Reports August 2025 Key Figures Performance Share Price NAV Swiss Exchange HBM Healthcare
BRIEF published on 09/01/2025 at 17:52, 8 months 10 days ago HBM Healthcare Investments AG publie ses chiffres clés d'août 2025 Performance NAV Cours De L'action Bourse Suisse HBM Santé
Published on 05/12/2026 at 06:00, 5 hours 30 minutes ago NOA Lithium Announces Strategic Collaboration with Hidrotec to Support NOA Projects
Published on 05/12/2026 at 04:20, 7 hours 10 minutes ago AI/ML Innovations Inc. Announces Closing of Final Tranche of Private Placement to Raise $1,917,500
Published on 05/12/2026 at 03:05, 8 hours 25 minutes ago UraniumX Reports Tragic Incident at Its Zoo Bay Property
Published on 05/12/2026 at 00:00, 11 hours 30 minutes ago PPX Mining Provides Update on Start-up of the Process Plant
Published on 05/12/2026 at 00:00, 11 hours 30 minutes ago Redwood AI Included in Innovate BC Investor Showcase: BC's Top 25 Investible Companies Event
Published on 05/12/2026 at 10:15, 1 hour 15 minutes ago EQS-Adhoc: aconnic AG announces improved fund raising plan to support business and refinance debt
Published on 05/12/2026 at 10:05, 1 hour 25 minutes ago Green Street Launches Green Street Infrastructure, Setting a New Standard for Real Assets Intelligence
Published on 05/12/2026 at 08:30, 3 hours ago Eiffage annonce le démarrage des travaux de construction du pôle universitaire du campus Grand Paris Nord à Saint-Ouen-sur-Seine
Published on 05/12/2026 at 08:30, 3 hours ago Eiffage announces launch of the construction work on the university hub of the Grand Paris Nord campus in Saint-Ouen-sur-Seine
